Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.
Kerkar SP, Goldszmid RS, Muranski P, Chinnasamy D, Yu Z, Reger RN, Leonardi AJ, Morgan RA, Wang E, Marincola FM, Trinchieri G, Rosenberg SA, Restifo NP.
J Clin Invest. 2011 Dec;121(12):4746-57. doi: 10.1172/JCI58814. Epub 2011 Nov 7.
Related citations
Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation.
Mauti LA, Le Bitoux MA, Baumer K, Stehle JC, Golshayan D, Provero P, Stamenkovic I.
J Clin Invest. 2011 Jul;121(7):2794-807. doi: 10.1172/JCI41936. Epub 2011 Jun 6.
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.
Benezra M, Penate-Medina O, Zanzonico PB, Schaer D, Ow H, Burns A, DeStanchina E, Longo V, Herz E, Iyer S, Wolchok J, Larson SM, Wiesner U, Bradbury MS.
J Clin Invest. 2011 Jul;121(7):2768-80. doi: 10.1172/JCI45600. Epub 2011 Jun 13.
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice.
Wang L, Fan J, Thompson LF, Zhang Y, Shin T, Curiel TJ, Zhang B.
J Clin Invest. 2011 Jun;121(6):2371-82. doi: 10.1172/JCI45559. Epub 2011 May 2.
Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients.
Baitsch L, Baumgaertner P, Devêvre E, Raghav SK, Legat A, Barba L, Wieckowski S, Bouzourene H, Deplancke B, Romero P, Rufer N, Speiser DE.
J Clin Invest. 2011 Jun;121(6):2350-60. doi: 10.1172/JCI46102. Epub 2011 May 9.
Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma.
Byrne KT, Côté AL, Zhang P, Steinberg SM, Guo Y, Allie R, Zhang W, Ernstoff MS, Usherwood EJ, Turk MJ.
J Clin Invest. 2011 May;121(5):1797-809. doi: 10.1172/JCI44849. Epub 2011 Apr 11.
Conditional ablation of Ikkb inhibits melanoma tumor development in mice.
Yang J, Splittgerber R, Yull FE, Kantrow S, Ayers GD, Karin M, Richmond A.
J Clin Invest. 2010 Jul;120(7):2563-74. doi: 10.1172/JCI42358. Epub 2010 Jun 7.
Early tumor dissemination, but late metastasis: insights into tumor dormancy.
Röcken M.
J Clin Invest. 2010 Jun;120(6):1800-3. doi: 10.1172/JCI43424. Epub 2010 May 24.
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.
Eyles J, Puaux AL, Wang X, Toh B, Prakash C, Hong M, Tan TG, Zheng L, Ong LC, Jin Y, Kato M, Prévost-Blondel A, Chow P, Yang H, Abastado JP.
J Clin Invest. 2010 Jun;120(6):2030-9. doi: 10.1172/JCI42002. Epub 2010 May 24.
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice.
Kottke T, Hall G, Pulido J, Diaz RM, Thompson J, Chong H, Selby P, Coffey M, Pandha H, Chester J, Melcher A, Harrington K, Vile R.
J Clin Invest. 2010 May;120(5):1551-60. doi: 10.1172/JCI41431. Epub 2010 Apr 1.
Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model.
Jablonska J, Leschner S, Westphal K, Lienenklaus S, Weiss S.
J Clin Invest. 2010 Apr;120(4):1151-64. doi: 10.1172/JCI37223. Epub 2010 Mar 8. Erratum in: J Clin Invest. 2010 Nov 1;120(11):4163.
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.
Derré L, Rivals JP, Jandus C, Pastor S, Rimoldi D, Romero P, Michielin O, Olive D, Speiser DE.
J Clin Invest. 2010 Jan;120(1):157-67. doi: 10.1172/JCI40070. Epub 2009 Dec 28.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on